FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Margaret Schot

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Roos L Oostendorp; Petronella O Witteveen; B Schwartz; L D Vainchtein; Margaret Schot; A Nol; Hilde Rosing; Jos H Beijnen; Emile E Voest; J H M Schellens
Dose-finding and pharmacokinetic study of orally administered indibulin (D-24851) to patients with advanced solid tumors.
Isa E L M Kuppens; Petronella O Witteveen; Margaret Schot; V M Schuessler; A Daehling; Jos H Beijnen; Emile E Voest; J H M Schellens
Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors.
H H Helgason; C M F Kruijtzer; Alwin D R Huitema; S G Marcus; Wim W ten Bokkel Huinink; Margaret Schot; Jan H Schornagel; Jos H Beijnen; J H M Schellens
Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Margaret Schot (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Roos L Oostendorp; Petronella O Witteveen; B Schwartz; L D Vainchtein; Margaret Schot; A Nol; Hilde Rosing; Jos H Beijnen; Emile E Voest; J H M Schellens
Dose-finding and pharmacokinetic study of orally administered indibulin (D-24851) to patients with advanced solid tumors.
Investigational new drugs 2010;28(2):163-70.
2007: Isa E L M Kuppens; Petronella O Witteveen; Margaret Schot; V M Schuessler; A Daehling; Jos H Beijnen; Emile E Voest; J H M Schellens
Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors.
Investigational new drugs 2007;25(3):227-35.
2006: H H Helgason; C M F Kruijtzer; Alwin D R Huitema; S G Marcus; Wim W ten Bokkel Huinink; Margaret Schot; Jan H Schornagel; Jos H Beijnen; J H M Schellens
Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer.
British journal of cancer 2006;95(7):794-800.
2003: Mirjam Crul; Nadja E Schoemaker; Dick Pluim; Marc Maliepaard; René W M Underberg; Margaret Schot; Rolf W Sparidans; Paul Baas; Jos H Beijnen; nico van zandwijk; Jan H M Schellens
Randomized phase I clinical and pharmacologic study of weekly versus twice-weekly dose-intensive cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 1):3526-33.
2003: C M F Kruijtzer; Henk Boot; Jos H Beijnen; H L Lochs; F X Parnis; A S T Planting; J M G Pelgrims; R Williams; Ron A A Mathôt; Hilde Rosing; Margaret Schot; Harm van Tinteren; J H M Schellens
Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):197-204.
2002: H J G Desirée van sen Bongard; Dick Pluim; Hilde Rosing; Lianda G A H Nan-Offeringa; Margaret Schot; Miroslav Ravic; Jan H M Schellens; Jos H Beijnen
An excretion balance and pharmacokinetic study of the novel anticancer agent E7070 in cancer patients.
Anti-cancer drugs 2002;13(8):807-14.
2002: Josefien C von Frijtag; Margaret Schot; Ruud van den Bos; Berry M Spruijt
Individual housing during the play period results in changed responses to and consequences of a psychosocial stress situation in rats.
Developmental psychobiology 2002;41(1):58-69.
2002: C M F Kruijtzer; Jos H Beijnen; Hilde Rosing; Wim W ten Bokkel Huinink; Margaret Schot; Roxanne C Jewell; Elaine M Paul; J H M Schellens
Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(13):2943-50.
2002: Jetske M Meerum Terwogt; Gerard Groenewegen; Dick Pluim; Marc Maliepaard; Matthijs M Tibben; Albert Huisman; Wim W ten Bokkel Huinink; Margaret Schot; Helen Welbank; Emile E Voest; Jos H Beijnen; Jan M Schellens
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
Cancer chemotherapy and pharmacology 2002;49(3):201-10.
2001: Mirte M Malingré; J H M Schellens; Olaf van Tellingen; Mariët Ouwehand; Heleen A Bardelmeijer; Hilde Rosing; FJ Koopman; Margaret Schot; Wim W ten Bokkel Huinink; Jos H Beijnen
The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients.
British journal of cancer 2001;85(10):1472-7.
2001: Jetske M Meerum Terwogt; Wim W ten Bokkel Huinink; J H M Schellens; Margaret Schot; IA Mandjes; M G Zurlo; M Rocchetti; Hilde Rosing; FJ Koopman; Jos H Beijnen
Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel.
Anti-cancer drugs 2001;12(4):315-23.
2001: Mirte M Malingré; Dick J Richel; Jos H Beijnen; Hilde Rosing; FJ Koopman; Wim W ten Bokkel Huinink; Margaret Schot; J H M Schellens
Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1160-6.
1999: Virginie M M Herben; R van Gijn; J H M Schellens; Margaret Schot; J Lieverst; Michel J X Hillebrand; Nadja E Schoemaker; M G Porro; Jos H Beijnen; Wim W ten Bokkel Huinink
Phase I and pharmacokinetic study of a daily times 5 short intravenous infusion schedule of 9-aminocamptothecin in a colloidal dispersion formulation in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1906-14.
1999: VR Nannan Panday; Ronald de Wit; Jan H Schornagel; Margaret Schot; Hilde Rosing; J Lieverst; Wim W ten Bokkel Huinink; J H M Schellens; Jos H Beijnen
Pharmacokinetics of paclitaxel administered in combination with cisplatin, etoposide and bleomycin in patients with advanced solid tumours.
Cancer chemotherapy and pharmacology 1999;44(4):349-53.
1998: Virginie M M Herben; Wim W ten Bokkel Huinink; Margaret Schot; IR Hudson; Jos H Beijnen
Continuous infusion of low-dose topotecan: pharmacokinetics and pharmacodynamics during a phase II study in patients with small cell lung cancer.
Anti-cancer drugs 1998;9(5):411-8.